Scientists find 'outlier' enzymes, potential new targets to treat diabetes, inflammation
Monday, March 28, 2016 - 12:20
in Health & Medicine
A team led by scientists at The Scripps Research Institute (TSRI) and the Salk Institute for Biological Studies has discovered two enzymes that appear to play a role in metabolism and inflammation—and might someday be targeted with drugs to treat type 2 diabetes and inflammatory disorders.